Heterogeneity of Islet-Infiltrating IL-21+ CD4 T Cells in a Mouse Model of Type 1 Diabetes
- 10 February 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 210 (7) , 935-946
Abstract
IL-21 is essential for type 1 diabetes (T1D) development in the NOD mouse model. IL-21–expressing CD4 T cells are present in pancreatic islets where they contribute to T1D progression. However, little is known about their phenotype and differentiation states. To fill this gap, we generated, to our knowledge, a novel IL-21 reporter NOD strain to further characterize IL-21+ CD4 T cells in T1D. IL-21+ CD4 T cells accumulate in pancreatic islets and recognize β cell Ags. Single-cell RNA sequencing revealed that CD4 T effector cells in islets actively express IL-21 and they are highly diabetogenic despite expressing multiple inhibitory molecules, including PD-1 and LAG3. Islet IL-21+ CD4 T cells segregate into four phenotypically and transcriptionally distinct differentiation states, that is, less differentiated early effectors, T follicular helper (Tfh)–like cells, and two Th1 subsets. Trajectory analysis predicts that early effectors differentiate into both Tfh-like and terminal Th1 cells. We further demonstrated that intrinsic IL-27 signaling controls the differentiation of islet IL-21+ CD4 T cells, contributing to their helper function. Collectively, our study reveals the heterogeneity of islet-infiltrating IL-21+ CD4 T cells and indicates that both Tfh-like and Th1 subsets produce IL-21 throughout their differentiation process, highlighting the important sources of IL-21 in T1D pathogenesis.Keywords
Funding Information
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK107541)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK121747)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI144360)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK097605)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK118786)
This publication has 57 references indexed in Scilit:
- An Interleukin-21- Interleukin-10-STAT3 Pathway Is Critical for Functional Maturation of Memory CD8+ T CellsImmunity, 2011
- Interleukin-21 Is Critically Required in Autoimmune and Allogeneic Responses to Islet Tissue in Murine ModelsDiabetes, 2011
- IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cellsJournal of Experimental Medicine, 2010
- Cutting Edge: IL-27 Induces the Transcription Factor c-Maf, Cytokine IL-21, and the Costimulatory Receptor ICOS that Coordinately Act Together to Promote Differentiation of IL-10-Producing Tr1 CellsThe Journal of Immunology, 2009
- A Vital Role for Interleukin-21 in the Control of a Chronic Viral InfectionScience, 2009
- IL-21 Is Required to Control Chronic Viral InfectionScience, 2009
- Interleukin-21 Is Required for the Development of Type 1 Diabetes in NOD MiceDiabetes, 2009
- The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cellsNature Immunology, 2008
- IL-21 signaling is critical for the development of type I diabetes in the NOD mouseProceedings of the National Academy of Sciences, 2008
- Generation of T Follicular Helper Cells Is Mediated by Interleukin-21 but Independent of T Helper 1, 2, or 17 Cell LineagesImmunity, 2008